Sonnet Biotherapeutics Holdings Inc (SONN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.26

About Sonnet Biotherapeutics Holdings Inc

Sonnet Biotherapeutics Holdings Inc. is a cutting-edge biotechnology company headquartered in Princeton, New Jersey, specializing in the development of novel oncological therapies through its proprietary platform for single-acting and bispecific biologics. By harnessing advanced technology, Sonnet is committed to creating targeted treatments that effectively address significant unmet medical needs in cancer care. With a strategic focus on next-generation biologics, the company is poised to le...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Sonnet Biotherapeutics Holdings Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SONN pay dividends?

Sonnet Biotherapeutics Holdings Inc (SONN) does not currently pay a regular dividend.